Cue Biopharma's total assets for Q1 2025 were $22.25M, a decrease of -30.87% from the previous quarter. CUE total liabilities were $15.67M for the fiscal quarter, a 6.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.